Pros
There really are none, industry exposure but you can get that at any biotech...
Cons
Higher level managers take forever to make decisions then press their lower-level employees to crank out bad data so they can save face when their indecisiveness causes delays. As much as they attempt to portray themselves as a great company with ample opportunity for growth, it is far from the truth. They prioritize promotions of directors and higher level positions even though RAs do the brunt of the work. Managers can be toxic and don't know how to manage people, are condescending, and do not know how to train properly. Good luck attempting to report any toxic behavior to HR because they do not keep anything confidential and will try to get rid of you if you report something to HR. Clinical has no idea what they're doing, and the stock price reflects the poor organization of clinical trials. There are always caveats to clinical trial data, usually because they take shortcuts to enroll patients quicker rather than focusing on producing good outcomes. They are consistently below median pay rates for RA positions, but of course managers and directors are compensated generously, and don't even get me started on the CEOs pay...